Ed Prideaux

Ed Prideaux argues that music in psychedelic trials, inherited unexamined from 1950s-70s LSD research, has culturally narrow, potentially coercive and memory-distorting effects and little evidence of therapeutic benefit, so it should either be rigorously tested or left to patient choice.

Britain's private medical cannabis industry has grown into a £240-300m market driven by aggressive subscription, referral and celebrity marketing, with prescribing concentrated in a handful of high-volume operators and oversight split across regulators, none of whom is watching the sector as a whole.

Britain's private medical cannabis clinics are aggressively marketing the drug for mental health conditions that the evidence doesn't support.

Part two of this investigation explores how Britain's private ketamine clinics operate with questionable testimonial practices, inconsistent safety and GP-liaison standards, unclear home-dosing arrangements, and no single regulator overseeing the whole pathway.

This investigation into Britain's roughly fifteen private ketamine clinics finds that their marketing claims about efficacy, safety, and prescriber credentials often outrun the evidence. Several declined to answer questions about safeguards.

Psychedelics can make false or distorted memories feel intensely vivid and 'true', and given weak safeguards in current therapy practice, this poses real risks of harm to patients and families.

Streaming's economics have turned psychedelic music from a genre of genuine innovation into a market for algorithmic nostalgia and AI-generated fakes, exposing how profit - not authenticity - decides what we hear.

Philosopher Tim Hsiao argues that recreational drug use is immoral because it deliberately impairs reason, our core human faculty. Ed Prideaux argues that his natural law framework is shaky, riddled with inconsistencies, and overlooks how altered states can sometimes serve, rather than undermine, human flourishing.